IGFBP3 encodes insulin-like growth factor binding protein 3 that has been shown to play a role both in the inflammatory processes and bone destruction observed in rheumatoid arthritis, and is considered a therapeutic agent candidate for treatment of this autoimmune and inflammatory disease40. The gene discussed is IGFBP3; the disease is rheumatoid arthritis.